Immune Cells in Cerebrospinal Fluid Predict Response of Brain Metastasis to Immunotherapy
Immune Cells in Cerebrospinal Fluid Predict Response of Brain Metastasis to Immunotherapy March 9, 2021 Studies by researchers at the Vall d’Hebron Institute of Oncology (VHIO), and the National Centre for Genomic Analysis-Centre for Genomic Regulation (CNAG-CRG), Barcelona, have demonstrated how immune cells that access the cerebrospinal fluid (CSF) of patients with brain metastases faithfully recapitulate the characteristics of the brain tumor immune cells, and could represent novel biomarkers of response to immune checkpoint inhibitor (ICI) therapy. The team used single-cell RNA sequenc...